We are live on ! Find out more
CGEM icon

Cullinan Oncology
CGEM

113 hedge funds and large institutions have $385M invested in Cullinan Oncology in 2023 Q4 according to their latest regulatory filings, with 23 funds opening new positions, 45 increasing their positions, 24 reducing their positions, and 14 closing their positions.

New
Increased
Maintained
Reduced
Closed

88% more repeat investments, than reductions

Existing positions increased: 45 | Existing positions reduced: 24

64% more first-time investments, than exits

New positions opened: 23 | Existing positions closed: 14

12% more capital invested

Capital invested by funds: $344M → $385M (+$41M)

7% more funds holding

Funds holding: 106 → 113 (+7)

0% more funds holding in top 10

Funds holding in top 10: 3 → 3 (0)

0.62% less ownership

Funds ownership: 88.93% → 88.31% (-0.62%)

12% less call options, than puts

Call options by funds: $97K | Put options by funds: $110K

Holders
113
Holders Change
+7
Holders Change %
+6.6%
% of All Funds
1.65%
Holding in Top 10
3
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.04%
New
23
Increased
45
Reduced
24
Closed
14
Calls
$97K
Puts
$110K
Net Calls
-$13K
Net Calls Change
+$467K

Top Buyers

Rank Fund Capital Flow
1
BOCH
Blue Owl Capital Holdings
New York
+$30.3M
2
Morgan Stanley
Morgan Stanley
New York
+$13.8M
3
Deutsche Bank
Deutsche Bank
Germany
+$4.79M
4
Franklin Resources
Franklin Resources
California
+$3.46M
5
AAA
Affinity Asset Advisors
New York
+$2.66M

Top Sellers

Rank Fund Capital Flow
1
Adage Capital Partners
Adage Capital Partners
Massachusetts
-$10.4M
2
BC
Boxer Capital
California
-$9.72M
3
B
Braidwell
Connecticut
-$5.92M
4
Assenagon Asset Management
Assenagon Asset Management
Luxembourg
-$5.51M
5
KCM
Kennedy Capital Management
Missouri
-$2.92M
Name Holding Trade Value Shares
Change 		Change in
Stake
KCM
26
Kennedy Capital Management
Missouri
$1.63M -$2.92M -329,434 -67%
SSA
27
Schonfeld Strategic Advisors
New York
$1.44M +$170K +19,200 +16%
UBS Group
28
UBS Group
Switzerland
$1.43M +$331K +37,316 +36%
Bank of America
29
Bank of America
North Carolina
$1.38M +$284K +32,095 +31%
Goldman Sachs
30
Goldman Sachs
New York
$1.31M +$374K +42,204 +49%
DCM
31
DAFNA Capital Management
California
$1.3M – – –
Verition Fund Management
32
Verition Fund Management
Connecticut
$1.15M -$859K -96,976 -46%
Bank of New York Mellon
33
Bank of New York Mellon
New York
$1.01M +$16.3K +1,844 +2%
First Trust Advisors
34
First Trust Advisors
Illinois
$946K +$20.4K +2,305 +3%
N
35
Nuveen
North Carolina
$900K +$86K +9,707 +12%
Barclays
36
Barclays
United Kingdom
$868K +$282K +31,831 +60%
CSS
37
Cubist Systematic Strategies
Connecticut
$580K +$215K +24,294 +74%
Ameriprise
38
Ameriprise
Minnesota
$560K -$68.1K -7,687 -12%
UOC
39
UBS O'Connor
Illinois
$554K -$449K -50,648 -48%
Two Sigma Investments
40
Two Sigma Investments
New York
$513K +$446K +50,342 New
D.E. Shaw & Co
41
D.E. Shaw & Co
New York
$498K +$81.7K +9,217 +23%
Swiss National Bank
42
Swiss National Bank
Switzerland
$472K +$68.2K +7,700 +20%
RhumbLine Advisers
43
RhumbLine Advisers
Massachusetts
$466K +$4.35K +491 +1%
AllianceBernstein
44
AllianceBernstein
Tennessee
$442K -$3.19K -360 -0.8%
CS
45
Credit Suisse
Switzerland
$437K +$208K +23,423 +120%
MAM
46
Martingale Asset Management
Massachusetts
$433K – – –
American Century Companies
47
American Century Companies
Missouri
$422K -$2.23M -251,400 -86%
AG
48
Algert Global
California
$418K +$217K +24,480 +148%
Prudential Financial
49
Prudential Financial
New Jersey
$409K +$40.4K +4,560 +13%
Two Sigma Advisers
50
Two Sigma Advisers
New York
$393K +$342K +38,600 New
1
2
3 4 5

CGEM Hedge Fund Activity: Q4 2023 in Review

113 of the 6,860 institutional investors tracked by Wall St. Rank reported a position in Cullinan Oncology (CGEM) for Q4 2023, worth a combined $385M — up 12% from $344M a quarter earlier.

Buyers outnumbered sellers: 23 funds opened new CGEM positions and 14 closed out — a net gain of 9 holders — while 45 added to existing stakes and 24 trimmed.

The largest buyer was Blue Owl Capital Holdings, opening a new position worth an estimated $30.3M. The largest seller was Adage Capital Partners, exiting entirely with an estimated $10.4M sold.

  • 113 institutional investors held Cullinan Oncology (CGEM) as of Q4 2023, up from 106 in Q3 2023.
  • Funds reported $385M of Cullinan Oncology stock for Q4 2023, up 12% quarter-over-quarter.
  • 23 funds opened new Cullinan Oncology positions in Q4 2023 and 14 closed out, a net change of +9 holders.
  • The largest Cullinan Oncology buyer in Q4 2023 was Blue Owl Capital Holdings, an estimated $30.3M added.
  • The largest Cullinan Oncology seller in Q4 2023 was Adage Capital Partners, an estimated $10.4M sold.

Based on aggregated 13F filings for Q4 2023.